To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution by the hon. Member for Havant of 3 February 2025, Official Report, column 552, for what reason the letter from AstraZeneca of 9 July 2025 to the Chancellor of the Exchequer and the Secretary of State for Science, Innovation and Technology received a delayed response.
The Government has had numerous discussions with AstraZeneca about their proposed investment into Speke. There were minor delays in replying to correspondence following the election period.
Astrazeneca